Janssen Loses La. Appeal Of $258M Risperdal Verdict
A Louisiana appeals court on Friday rejected an attempt by the pharmaceuticals unit of consumer products giant Johnson & Johnson to vacate a jury award of $258 million over its marketing...To view the full article, register now.
Already a subscriber? Click here to view full article